Skip to main content
. Author manuscript; available in PMC: 2009 Oct 25.
Published in final edited form as: Int J Gynecol Cancer. 2009 May;19(4):508–512. doi: 10.1111/IGC.0b013e3181a388c4

Figure 2.

Figure 2

Response to IFN-g ELISpot HPV16 E7 among groups of women with evidence of HPV16: recent clearance (RC), past clearance (PC), clearance after transient infection (TI), intermittent positive (IP) and recent persistence (RP)